State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Methods Mol Biol. 2023;2676:265-284. doi: 10.1007/978-1-0716-3251-2_19.
Genetic code expansion enables in cellulo biosynthesis of curative proteins with enhanced specificity, improved stability, and even novel functions, due to the incorporation of artificial, designed, noncanonical amino acids (ncAAs). In addition, this orthogonal system also holds great potential for in vivo suppressing nonsense mutations during protein translation, providing an alternative strategy for alleviating inherited diseases caused by premature termination codons (PTCs). Here we describe the approach to explore the therapeutic efficacy and long-term safety of this strategy in transgenic mdx mice with stably expanded genetic codes. Theoretically, this method is applicable to about 11% of monogenic diseases involving nonsense mutations.
遗传密码扩展使我们能够在细胞内生物合成具有增强的特异性、改善的稳定性甚至新功能的治疗性蛋白质,这要归功于人工设计的非规范氨基酸(ncAAs)的掺入。此外,该正交系统在蛋白质翻译过程中抑制无意义突变也具有很大的潜力,为缓解由过早终止密码子(PTC)引起的遗传性疾病提供了一种替代策略。在这里,我们描述了在具有稳定扩展遗传密码的转基因 mdx 小鼠中探索这种策略的治疗效果和长期安全性的方法。从理论上讲,这种方法适用于约 11%涉及无意义突变的单基因疾病。